230 related articles for article (PubMed ID: 22707254)
1. Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts.
Lenz B; Schöpp E; Müller CP; Bleich S; Hillemacher T; Kornhuber J
Psychopharmacology (Berl); 2012 Dec; 224(3):421-9. PubMed ID: 22707254
[TBL] [Abstract][Full Text] [Related]
2. The TTTAn aromatase (CYP19A1) polymorphism is associated with compulsive craving of male patients during alcohol withdrawal.
Lenz B; Heberlein A; Bayerlein K; Frieling H; Kornhuber J; Bleich S; Hillemacher T
Psychoneuroendocrinology; 2011 Sep; 36(8):1261-4. PubMed ID: 21414724
[TBL] [Abstract][Full Text] [Related]
3. Association of Testosterone Levels and Steroid 5-Alpha-Reductase 2 Polymorphisms with Opioid Craving.
Janke E; Groh A; Mühle C; Dürsteler-MacFarland KM; Wiesbeck GA; Kornhuber J; Jahn K; Groeschl M; Lichtinghagen R; Frieling H; Bleich S; Hillemacher T; Lenz B; Heberlein A
Neuropsychobiology; 2021; 80(1):64-73. PubMed ID: 32659769
[TBL] [Abstract][Full Text] [Related]
4. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.
Torkko KC; van Bokhoven A; Mai P; Beuten J; Balic I; Byers TE; Hokanson JE; Norris JM; Barón AE; Lucia MS; Thompson IM; Leach RJ
Clin Cancer Res; 2008 May; 14(10):3223-9. PubMed ID: 18483391
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
6. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of the long polyglutamine tract in the human androgen receptor influences craving of men in alcohol withdrawal.
Lenz B; Jacob C; Frieling H; Jacobi A; Hillemacher T; Muschler M; Watson K; Kornhuber J; Bleich S
Psychoneuroendocrinology; 2009 Aug; 34(7):968-71. PubMed ID: 19231085
[TBL] [Abstract][Full Text] [Related]
8. The modulating effect of the androgen receptor on craving in alcohol withdrawal of men is partially mediated by leptin.
Lenz B; Frieling H; Jacob C; Heberlein A; Kornhuber J; Bleich S; Hillemacher T
Pharmacogenomics J; 2010 Jun; 10(3):226-31. PubMed ID: 19884906
[TBL] [Abstract][Full Text] [Related]
9. SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer.
Choubey VK; Sankhwar SN; Carlus SJ; Singh AN; Dalela D; Thangaraj K; Rajender S
Asian Pac J Cancer Prev; 2015; 16(3):1033-6. PubMed ID: 25735326
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic markers in the 5alpha-reductase type II gene and the incidence of prostate cancer.
Lamharzi N; Johnson MM; Goodman G; Etzioni R; Weiss NS; Dightman DA; Barnett M; DiTommaso D; Chen C
Int J Cancer; 2003 Jul; 105(4):480-3. PubMed ID: 12712437
[TBL] [Abstract][Full Text] [Related]
11. Associations between the SRD5A2 gene V89L and TA repeat polymorphisms and breast cancer risk: a meta-analysis.
Zhang D; Li Q; Qu HC; Yu T; Liu YR
Genet Mol Res; 2015 Aug; 14(3):9004-12. PubMed ID: 26345832
[TBL] [Abstract][Full Text] [Related]
12. SRD5A2 gene polymorphisms affect the risk of breast cancer.
Francis A; Sarkar S; Pooja S; Surekha D; Rao DR; Rao L; Ramachandra L; Vishnupriya S; Satyamoorthy K; Thangaraj K; Rajender S
Breast; 2014 Apr; 23(2):137-41. PubMed ID: 24365257
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
14. 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.
Söderström T; Wadelius M; Andersson SO; Johansson JE; Johansson S; Granath F; Rane A
Pharmacogenetics; 2002 Jun; 12(4):307-12. PubMed ID: 12042668
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation of the LEP gene is associated with craving during alcohol withdrawal.
Hillemacher T; Weinland C; Lenz B; Kraus T; Heberlein A; Glahn A; Muschler MA; Bleich S; Kornhuber J; Frieling H
Psychoneuroendocrinology; 2015 Jan; 51():371-7. PubMed ID: 25462909
[TBL] [Abstract][Full Text] [Related]
16. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
17. Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.
Li Q; Zhu Y; He J; Wang M; Zhu M; Shi T; Qiu L; Ye D; Wei Q
Mol Biol Rep; 2013 May; 40(5):3597-608. PubMed ID: 23277398
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
Li X; Huang Y; Fu X; Chen C; Zhang D; Yan L; Xie Y; Mao Y; Li Y
Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
[TBL] [Abstract][Full Text] [Related]
19. [V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer].
Tong M; Jin YY; Li G; Liu SM; Ji CD
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):990-3. PubMed ID: 21218640
[TBL] [Abstract][Full Text] [Related]
20. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.
Yu MW; Yang YC; Yang SY; Cheng SW; Liaw YF; Lin SM; Chen CJ
J Natl Cancer Inst; 2001 Nov; 93(21):1644-51. PubMed ID: 11698569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
